Bachem exhibits at DCAT week
Press Release | Bachem AG
MARCH 04, 2015
Bubendorf, Switzerland: – Peptide technology specialist Bachem is bringing its new innovative products and services to North America’s high-prestige DCAT Week.
Bachem will be represented at DCAT by its US subsidiary, Bachem Americas Inc. of Torrance, CA. This will be the company’s first DCAT appearance since a landmark rebranding last April provided the Swiss-based CMO with a colorful new look and a re-engineered web presence.
Pioneering Partner for Peptides.
The Bachem team at DCAT will be explaining how their new corporate strapline,‘Pioneering Partner for Peptides’ describes an organization that actively supports clients through all phases of active ingredient development.
The team will be busy throughout DCAT week, using the event’s unique format and networking opportunities to discuss potential collaborations that can harness Bachem’s outstanding knowledge of peptide chemistry.
Bachem will also be using DCAT to offer exciting opportunities such as the innovative chemical glycosylation of peptides, which has the potential to improve the physicochemical properties of active ingredients. Bachem’s process has been award nominee, because it has enabled a production scalable chemical synthesis of Interferon β-1a.
The Bachem team will also present the company’s large portfolio of peptide and small molecule generic APIs and other services such as custom manufacturing, and sterile fill and finish products (Clinalfa) for use in approved clinical studies.
Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and peptides for research labs and exclusive custom syntheses complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership.
About DCAT Week
The Drug, Chemical & Associated Technologies Association (DCAT) was founded in 1890 and has become North America’s premier business development association for companies that manufacture, distribute or provide services to the pharmaceutical and chemical industries.
DCAT represents the entire spectrum of the pharmaceutical industry—from pharmaceutical, API, and excipient sales and manufacturing to distribution, support technologies and packaging products and services.
DCAT is the only association that brings the industry’s buyers and sellers together, providing services, programs and events designed to support the business development objectives of its membership.
Attended by thousands of industry professionals, DCAT Week® and the DCAT Annual Dinner, held each March in New York City, are considered one of the pharma industry’s premier events.
DCAT Week 2015 will celebrate the organizations 125th anniversary and will take place from March 16 to March 19 and, as usual, will be headquartered at the Waldorf Astoria Hotel.
Unlike most industry exhibitions, DCAT Week is not a trade show with stands or booths. Instead, DCAT members hold high-level strategic meetings with customers and suppliers in a block of business meeting suites across a range of prestige NYC hotels, including the New York Palace, Lexington and Hyatt 48 Lex.
DCAT members make their own appointments, some scheduling upwards of 100 meetings during the week.
More information at: http://www.dcat.org/Pages/Home.aspx
Dr. Martina Diekmann, Head of Global Marketing, Bachem Group
Tel: +41 61 935 2333